;PMID: 9658319
;source_file_1217.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..37] = [t:0..37]
;1)sentence:[e:42..149] = [t:42..149]
;2)section:[e:153..211] = [t:153..211]
;3)section:[e:215..307] = [t:215..307]
;4)sentence:[e:311..460] = [t:311..460]
;5)sentence:[e:461..578] = [t:461..578]
;6)sentence:[e:579..761] = [t:579..761]
;7)sentence:[e:762..910] = [t:762..910]
;8)sentence:[e:911..1033] = [t:911..1033]
;9)sentence:[e:1034..1108] = [t:1034..1108]
;10)sentence:[e:1109..1194] = [t:1109..1194]
;11)sentence:[e:1195..1342] = [t:1195..1342]
;12)sentence:[e:1343..1518] = [t:1343..1518]
;13)section:[e:1522..1566] = [t:1522..1566]

;section 0 Span:0..37
;J Gastroenterol  1998 Jun;33(3):390-6
(SEC
  (FRAG (DT:[0..1] J) (NNP:[2..15] Gastroenterol) (CD:[17..21] 1998)
        (CC:[22..29] Jun;33-LRB-) (CD:[29..30] 3) (-RRB-:[30..31] -RRB-)
        (CD:[31..35] :390) (::[35..36] -) (CD:[36..37] 6)))

;sentence 1 Span:42..149
;Detection of Ki-ras and p53 gene mutations in tissue and pancreatic juice
;from  pancreatic adenocarcinomas.
;[55..61]:gene-rna:"Ki-ras"
;[66..69]:gene-rna:"p53"
;[122..148]:malignancy:"pancreatic adenocarcinomas"
(SENT
  (NP-HLN
    (NP (NN:[42..51] Detection))
    (PP (IN:[52..54] of)
      (NP
        (NP (NN:[55..61] Ki-ras)
          (NML-1 (-NONE-:[61..61] *P*)))
        (CC:[62..65] and)
        (NP (NN:[66..69] p53)
          (NML-1 (NN:[70..74] gene) (NNS:[75..84] mutations)))))
    (PP-LOC (IN:[85..87] in)
      (NP
        (NP (NN:[88..94] tissue))
        (CC:[95..98] and)
        (NP (JJ:[99..109] pancreatic) (NN:[110..115] juice))))
    (PP (IN:[116..120] from)
      (NP (JJ:[122..132] pancreatic) (NNS:[133..148] adenocarcinomas)))
    (.:[148..149] .)))

;section 2 Span:153..211
;Kondoh S, Kaino M, Okita S, Ryozawa S, Akiyama T, Okita K.
(SEC
  (FRAG (NNP:[153..159] Kondoh) (NNP:[160..162] S,) (NNP:[163..168] Kaino)
        (NNP:[169..171] M,) (NNP:[172..177] Okita) (NNP:[178..180] S,)
        (NNP:[181..188] Ryozawa) (NNP:[189..191] S,) (NNP:[192..199] Akiyama)
        (NNP:[200..201] T) (,:[201..202] ,) (NNP:[203..208] Okita)
        (NNP:[209..211] K.)))

;section 3 Span:215..307
;First Department of Internal Medicine, Yamaguchi University School of
;Medicine,  Ube, Japan.
(SEC
  (FRAG (NNP:[215..220] First) (NNP:[221..231] Department) (IN:[232..234] of)
        (NNP:[235..243] Internal) (NNP:[244..252] Medicine) (,:[252..253] ,)
        (NNP:[254..263] Yamaguchi) (NNP:[264..274] University)
        (NNP:[275..281] School) (IN:[282..284] of) (NNP:[285..293] Medicine)
        (,:[293..294] ,) (NNP:[296..299] Ube) (,:[299..300] ,)
        (NNP:[301..306] Japan) (.:[306..307] .)))

;sentence 4 Span:311..460
;Pancreatic carcinomas have a high incidence of Ki-ras mutations, and the
;genetic  change is thought to occur at an early stage in the carcinogenesis.
;[311..332]:malignancy:"Pancreatic carcinomas"
;[358..364]:gene-rna:"Ki-ras"
(SENT
  (S
    (S
      (NP-SBJ (JJ:[311..321] Pancreatic) (NNS:[322..332] carcinomas))
      (VP (VBP:[333..337] have)
        (NP
          (NP (DT:[338..339] a) (JJ:[340..344] high) (NN:[345..354] incidence))
          (PP (IN:[355..357] of)
            (NP (NN:[358..364] Ki-ras) (NNS:[365..374] mutations))))))
    (,:[374..375] ,) (CC:[376..379] and)
    (S
      (NP-SBJ-1 (DT:[380..383] the) (JJ:[384..391] genetic)
                (NN:[393..399] change))
      (VP (VBZ:[400..402] is)
        (VP (VBN:[403..410] thought)
          (S
            (NP-SBJ-1 (-NONE-:[410..410] *))
            (VP (TO:[411..413] to)
              (VP (VB:[414..419] occur)
                (PP (IN:[420..422] at)
                  (NP
                    (NP (DT:[423..425] an) (JJ:[426..431] early)
                        (NN:[432..437] stage))
                    (PP (IN:[438..440] in)
                      (NP (DT:[441..444] the) (NN:[445..459] carcinogenesis)))))))))))
    (.:[459..460] .)))

;sentence 5 Span:461..578
;The aim of  this study was to evaluate the usefulness of detecting genetic
;mutations in pure  pancreatic juice (PPJ).
(SENT
  (S
    (NP-SBJ
      (NP (DT:[461..464] The) (NN:[465..468] aim))
      (PP (IN:[469..471] of)
        (NP (DT:[473..477] this) (NN:[478..483] study))))
    (VP (VBD:[484..487] was)
      (S-PRD
        (NP-SBJ (-NONE-:[487..487] *))
        (VP (TO:[488..490] to)
          (VP (VB:[491..499] evaluate)
            (NP
              (NP (DT:[500..503] the) (NN:[504..514] usefulness))
              (PP (IN:[515..517] of)
                (S-NOM
                  (NP-SBJ (-NONE-:[517..517] *))
                  (VP (VBG:[518..527] detecting)
                    (NP (JJ:[528..535] genetic) (NNS:[536..545] mutations))
                    (PP-LOC (IN:[546..548] in)
                      (NP
                        (NP (JJ:[549..553] pure) (JJ:[555..565] pancreatic)
                            (NN:[566..571] juice))
                        (NP (-LRB-:[572..573] -LRB-) (NN:[573..576] PPJ)
                            (-RRB-:[576..577] -RRB-))))))))))))
    (.:[577..578] .)))

;sentence 6 Span:579..761
;DNA was extracted from tissue specimens of pancreatic  carcinomas and from
;cells in PPJ, and subjected to polymerase chain  reaction-single-strand
;conformation polymorphism analysis.
;[622..644]:malignancy:"pancreatic  carcinomas"
;[685..695]:gene-protein:"polymerase"
(SENT
  (S
    (NP-SBJ-1 (NN:[579..582] DNA))
    (VP (VBD:[583..586] was)
      (VP
        (VP (VBN:[587..596] extracted)
          (NP-1 (-NONE-:[596..596] *))
          (PP
            (PP (IN:[597..601] from)
              (NP
                (NP (NN:[602..608] tissue) (NNS:[609..618] specimens))
                (PP (IN:[619..621] of)
                  (NP (JJ:[622..632] pancreatic) (NNS:[634..644] carcinomas)))))
            (CC:[645..648] and)
            (PP (IN:[649..653] from)
              (NP
                (NP (NNS:[654..659] cells))
                (PP (IN:[660..662] in)
                  (NP (NN:[663..666] PPJ)))))))
        (,:[666..667] ,) (CC:[668..671] and)
        (VP (VBN:[672..681] subjected)
          (NP-1 (-NONE-:[681..681] *))
          (PP (TO:[682..684] to)
            (NP
              (NML
                (NML (NN:[685..695] polymerase) (NN:[696..701] chain)
                     (NN:[703..711] reaction))
                (HYPH:[711..712] -)
                (NML
                  (NML (JJ:[712..718] single) (HYPH:[718..719] -)
                       (NN:[719..725] strand))
                  (NN:[726..738] conformation) (NN:[739..751] polymorphism)))
              (NN:[752..760] analysis))))))
    (.:[760..761] .)))

;sentence 7 Span:762..910
;Two types of mobility  shifts that indicate Ki-ras mutations were observed in
;13 of the 20 (65%) tissue  specimens obtained by operation or autopsy.
;[806..812]:gene-rna:"Ki-ras"
(SENT
  (S
    (NP-SBJ-2
      (NP (CD:[762..765] Two) (NNS:[766..771] types))
      (PP (IN:[772..774] of)
        (NP
          (NP (NN:[775..783] mobility) (NNS:[785..791] shifts))
          (SBAR
            (WHNP-1 (WDT:[792..796] that))
            (S
              (NP-SBJ-1 (-NONE-:[796..796] *T*))
              (VP (VBP:[797..805] indicate)
                (NP (NN:[806..812] Ki-ras) (NNS:[813..822] mutations))))))))
    (VP (VBD:[823..827] were)
      (VP (VBN:[828..836] observed)
        (NP-2 (-NONE-:[836..836] *))
        (PP-LOC (IN:[837..839] in)
          (NP
            (NP (CD:[840..842] 13))
            (PP (IN:[843..845] of)
              (NP
                (NP (DT:[846..849] the) (CD:[850..852] 20)
                  (PRN (-LRB-:[853..854] -LRB-)
                    (NP (CD:[854..856] 65) (NN:[856..857] %))
                    (-RRB-:[857..858] -RRB-))
                  (NN:[859..865] tissue) (NNS:[867..876] specimens))
                (VP (VBN:[877..885] obtained)
                  (NP (-NONE-:[885..885] *))
                  (PP-MNR (IN:[886..888] by)
                    (NP (NN:[889..898] operation) (CC:[899..901] or)
                        (NN:[902..909] autopsy))))))))))
    (.:[909..910] .)))

;sentence 8 Span:911..1033
;Ten of 15 specimens (67%) of PPJ  collected from patients with pancreatic
;carcinomas showed two types of mobility  shifts.
;[974..995]:malignancy:"pancreatic carcinomas"
(SENT
  (S
    (NP-SBJ
      (NP
        (NP
          (NP (CD:[911..914] Ten))
          (PP (IN:[915..917] of)
            (NP (CD:[918..920] 15) (NNS:[921..930] specimens)))
          (PRN (-LRB-:[931..932] -LRB-)
            (NP (CD:[932..934] 67) (NN:[934..935] %))
            (-RRB-:[935..936] -RRB-)))
        (PP (IN:[937..939] of)
          (NP (NN:[940..943] PPJ))))
      (VP (VBN:[945..954] collected)
        (NP (-NONE-:[954..954] *))
        (PP (IN:[955..959] from)
          (NP
            (NP (NNS:[960..968] patients))
            (PP (IN:[969..973] with)
              (NP (JJ:[974..984] pancreatic) (NNS:[985..995] carcinomas)))))))
    (VP (VBD:[996..1002] showed)
      (NP
        (NP (CD:[1003..1006] two) (NNS:[1007..1012] types))
        (PP (IN:[1013..1015] of)
          (NP (NN:[1016..1024] mobility) (NNS:[1026..1032] shifts)))))
    (.:[1032..1033] .)))

;sentence 9 Span:1034..1108
;Conventional imaging techniques did not show two in 10 of these  patients.
(SENT
  (S
    (NP-SBJ (JJ:[1034..1046] Conventional) (NN:[1047..1054] imaging)
            (NNS:[1055..1065] techniques))
    (VP (VBD:[1066..1069] did) (RB:[1070..1073] not)
      (VP (VB:[1074..1078] show)
        (NP
          (NP (CD:[1079..1082] two))
          (PP (IN:[1083..1085] in)
            (NP
              (NP (CD:[1086..1088] 10))
              (PP (IN:[1089..1091] of)
                (NP (DT:[1092..1097] these) (NNS:[1099..1107] patients))))))))
    (.:[1107..1108] .)))

;sentence 10 Span:1109..1194
;PPJ from patients with non-cancerous pancreatic diseases showed no  Ki-ras
;mutations.
;[1177..1183]:gene-rna:"Ki-ras"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1109..1112] PPJ))
      (PP (IN:[1113..1117] from)
        (NP
          (NP (NNS:[1118..1126] patients))
          (PP (IN:[1127..1131] with)
            (NP
              (ADJP (AFX:[1132..1135] non) (HYPH:[1135..1136] -)
                    (JJ:[1136..1145] cancerous))
              (JJ:[1146..1156] pancreatic) (NNS:[1157..1165] diseases))))))
    (VP (VBD:[1166..1172] showed)
      (NP (DT:[1173..1175] no) (NN:[1177..1183] Ki-ras)
          (NNS:[1184..1193] mutations)))
    (.:[1193..1194] .)))

;sentence 11 Span:1195..1342
;The p53 tumor suppressor gene, examined by PCR-SSCP analysis,  was mutated in
;8 of the 20 tissue specimens obtained by operation or autopsy  (40%).
;[1199..1202]:gene-rna:"p53"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[1195..1198] The) (NN:[1199..1202] p53)
        (NML (NN:[1203..1208] tumor) (NN:[1209..1219] suppressor))
        (NN:[1220..1224] gene))
      (,:[1224..1225] ,)
      (VP (VBN:[1226..1234] examined)
        (NP (-NONE-:[1234..1234] *))
        (PP-MNR (IN:[1235..1237] by)
          (NP
            (NML (NN:[1238..1241] PCR) (HYPH:[1241..1242] -)
                 (NN:[1242..1246] SSCP))
            (NN:[1247..1255] analysis)))))
    (,:[1255..1256] ,)
    (VP (VBD:[1258..1261] was)
      (VP (VBN:[1262..1269] mutated)
        (NP-1 (-NONE-:[1269..1269] *))
        (PP-LOC (IN:[1270..1272] in)
          (NP
            (NP (CD:[1273..1274] 8))
            (PP (IN:[1275..1277] of)
              (NP
                (NP (DT:[1278..1281] the) (CD:[1282..1284] 20)
                    (NN:[1285..1291] tissue) (NNS:[1292..1301] specimens))
                (VP (VBN:[1302..1310] obtained)
                  (NP (-NONE-:[1310..1310] *))
                  (PP-MNR (IN:[1311..1313] by)
                    (NP (NN:[1314..1323] operation) (CC:[1324..1326] or)
                        (NN:[1327..1334] autopsy)))
                  (PRN (-LRB-:[1336..1337] -LRB-)
                    (NP (CD:[1337..1339] 40) (NN:[1339..1340] %))
                    (-RRB-:[1340..1341] -RRB-)))))))))
    (.:[1341..1342] .)))

;sentence 12 Span:1343..1518
;The detection of Ki-ras and p53 mutations in PPJ could be useful for the 
;early diagnosis of pancreatic carcinomas, especially for neoplastic lesions
;of  the intraductal type.
;[1360..1366]:gene-rna:"Ki-ras"
;[1371..1374]:gene-rna:"p53"
;[1436..1457]:malignancy:"pancreatic carcinomas"
;[1474..1517]:malignancy:"neoplastic lesions of  the intraductal type"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1343..1346] The) (NN:[1347..1356] detection))
      (PP (IN:[1357..1359] of)
        (NP
          (NP (NN:[1360..1366] Ki-ras)
            (NML-1 (-NONE-:[1366..1366] *P*)))
          (CC:[1367..1370] and)
          (NP (NN:[1371..1374] p53)
            (NML-1 (NNS:[1375..1384] mutations)))))
      (PP-LOC (IN:[1385..1387] in)
        (NP (NN:[1388..1391] PPJ))))
    (VP (MD:[1392..1397] could)
      (VP (VB:[1398..1400] be)
        (ADJP-PRD (JJ:[1401..1407] useful)
          (PP (IN:[1408..1411] for)
            (NP
              (NP (DT:[1412..1415] the) (JJ:[1417..1422] early)
                  (NN:[1423..1432] diagnosis))
              (PP (IN:[1433..1435] of)
                (NP (JJ:[1436..1446] pancreatic) (NNS:[1447..1457] carcinomas)))))
          (,:[1457..1458] ,)
          (PP
            (ADVP (RB:[1459..1469] especially))
            (IN:[1470..1473] for)
            (NP
              (NP (JJ:[1474..1484] neoplastic) (NNS:[1485..1492] lesions))
              (PP (IN:[1493..1495] of)
                (NP (DT:[1497..1500] the) (JJ:[1501..1512] intraductal)
                    (NN:[1513..1517] type))))))))
    (.:[1517..1518] .)))

;section 13 Span:1522..1566
;PMID: 9658319 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1522..1526] PMID) (::[1526..1527] :) (CD:[1528..1535] 9658319)
        (NN:[1536..1537] -LSB-) (NNP:[1537..1543] PubMed) (::[1544..1545] -)
        (NN:[1546..1553] indexed) (IN:[1554..1557] for)
        (NNP:[1558..1566] MEDLINE-RSB-)))
